Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Change in Inventory (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Change in Inventory for 6 consecutive years, with $4.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Inventory fell 31.03% to $4.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $14.5 million, a 15.88% decrease, with the full-year FY2025 number at $14.5 million, down 15.88% from a year prior.
  • Change in Inventory was $4.0 million for Q4 2025 at PROCEPT BioRobotics, up from -$568000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $10.1 million in Q1 2023 to a low of -$3.2 million in Q4 2023.
  • A 5-year average of $3.1 million and a median of $2.7 million in 2021 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: crashed 155.83% in 2022, then soared 2060.54% in 2023.
  • PROCEPT BioRobotics' Change in Inventory stood at $2.5 million in 2021, then surged by 125.98% to $5.7 million in 2022, then crashed by 155.42% to -$3.2 million in 2023, then soared by 281.95% to $5.8 million in 2024, then plummeted by 31.03% to $4.0 million in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Change in Inventory are $4.0 million (Q4 2025), -$568000.0 (Q3 2025), and $4.8 million (Q2 2025).